Solstice, which uses clinical and compliance documents and AI to accelerate advertising approvals for pharma clients, raised a $21M Series A (Brock E.W. Turner/Axios)

Brock E.W. Turner / Axios: Solstice, which uses clinical and compliance documents and AI to accelerate advertising approvals for pharma clients, raised a $21M Series A — Pharma marketing company Solstice raised $21 million in Series A funding led by Transformation Capital, CEO Aris Saxena tells Axios Pro exclusively.